Argenx SE Files Routine 6-K Report
Ticker: ARGX · Form: 6-K · Filed: Jul 25, 2024 · CIK: 1697862
Sentiment: neutral
Topics: sec-filing, 6-K, regulatory-update
Related Tickers: ARGX
TL;DR
ARGENX filed a 6-K, standard report, no major news.
AI Summary
Argenx SE filed a Form 6-K on July 25, 2024, reporting its financial and operational status as of June 30, 2024. The filing is a routine report for foreign private issuers and does not contain specific financial results or material events beyond its periodic disclosure requirements.
Why It Matters
This filing provides an update on Argenx SE's status as a foreign private issuer, which is important for investors tracking regulatory compliance and periodic disclosures.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new material financial information or strategic announcements.
Key Players & Entities
- ARGENX SE (company) — Filer of the report
- 0001558370-24-010095 (filing_id) — Accession number for the filing
- 20240725 (date) — Date of filing
- 20240630 (date) — Period of report
FAQ
What type of report is Argenx SE filing?
Argenx SE is filing a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What period does this 6-K report cover?
The Conformed Period of Report for this filing is June 30, 2024.
When was this Form 6-K filed?
This Form 6-K was filed on July 25, 2024.
Is Argenx SE required to file Form 20-F or 40-F?
Argenx SE indicates it files annual reports under cover of Form 20-F.
What is the principal executive office address for Argenx SE?
The principal executive offices are located at Laarderhoogtweg 25, 1101 EB Amsterdam, the Netherlands.
Filing Stats: 392 words · 2 min read · ~1 pages · Grade level 11.9 · Accepted 2024-07-25 06:01:40
Filing Documents
- argx-20240630x6k.htm (6-K) — 35KB
- argx-20240630xex99d1.htm (EX-99.1) — 158KB
- argx-20240630xex99d2.htm (EX-99.2) — 1106KB
- argx-20240630xex99d1001.jpg (GRAPHIC) — 3KB
- 0001558370-24-010095.txt ( ) — 4613KB
- argx-20240630.xsd (EX-101.SCH) — 54KB
- argx-20240630_cal.xml (EX-101.CAL) — 67KB
- argx-20240630_def.xml (EX-101.DEF) — 105KB
- argx-20240630_lab.xml (EX-101.LAB) — 333KB
- argx-20240630_pre.xml (EX-101.PRE) — 222KB
- argx-20240630xex99d2_htm.xml (XML) — 718KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ARGENX SE Date: July 25, 2024 By: /s/ Hemamalini (Malini) Moorthy Hemamalini (Malini) Moorthy General Counsel